— Know what they know.
Not Investment Advice
Also trades as: 4272.T (JPX) · $vol 8M · NPKYF (OTC) · $vol 0M

NPKYY OTC

Nippon Kayaku Co., Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +28.6% 1Y: +55.6% 3Y: +57.8% 5Y: +47.2%
$13.16
+0.00 (+0.00%)
 
OTC · Basic Materials · Chemicals · Tech Score Sell · Power 45 · $2.0B mcap · 132M float · 0.0000% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.0B
52W Range8.46-14.05
Volume11
Avg Volume12
Beta0.54
Dividend$0.25
Analyst Ratings
No analyst coverage
Company Info
CEOShigeyuki Kawamura
Employees5,946
SectorBasic Materials
IndustryChemicals
IPO Date2012-08-03
Meiji Yasuda Seimei Building
Tokyo, TY 100-0005
JP
81 3 6731 5200
About Nippon Kayaku Co., Ltd.

Nippon Kayaku Co., Ltd., an established Japanese enterprise with global operations and various subsidiaries, specializes in the development, manufacturing, and distribution of a diverse array of products. These encompass specialized chemicals, pharmaceutical goods, safety components, and agricultural solutions. The company's headquarters are located in Tokyo, Japan, and it was originally founded in 1916 as Nihon Kayaku Seizou Co., Ltd., before adopting its current name in 1945. Its diversified operations are structured into several key segments: Functional Chemicals Business: This division delivers advanced materials such as epoxy and UV-curable resins, specialized sealants for LCD and LED displays, maleimide resins, photoresists, and insulating materials vital for micro electromechanical systems (MEMS), along with various cleaning agents. It also produces an assortment of color materials, including inkjet colorants, dyes for textile and paper applications, and substances for thermal paper. Additionally, this segment supplies catalysts for the production of acrylic and methacrylic acid, and optical components like polarizing films, inorganic polarizers, liquid crystal display parts, projector components, and elements used in X-ray analysis. Pharmaceuticals Business: This arm focuses on a range of therapeutic areas, offering anti-cancer and cancer-related medications, biosimilars, and generic drugs. The portfolio also includes interventional radiology products, cardiovascular treatments, bulk drug substances, and pharmaceutical intermediates. Furthermore, it provides drugs for diagnosing cancer and markets GlycoMark, a diagnostic tool for monitoring blood sugar control in diabetic patients. Safety Systems Business: This unit manufactures critical components for automotive safety, including airbag inflators, miniature gas generators designed for seatbelt pretensioners, and squibs. Agrochemicals Business: This segment provides products for crop protection and pest control, such as agricultural insecticides, herbicides, soil fumigants, and solutions for public health insecticide applications. Beyond its core product lines, the company also maintains involvement in real estate leasing services.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms